openPR Logo
Press release

Single Cell Genome Sequencing Market Clinical Review, Analysis And Synthesis 2018-2026 With Top Players Illumina, Fludigim Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche, QIAGEN

07-02-2019 02:40 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Single Cell Genome Sequencing

Single Cell Genome Sequencing

Single cell genome sequencing involves isolating a single cell and amplifying and sequencing genes within that single cell. Sequencing single cell carries significant importance as individual cells can differ at great extent in size, protein levels, and expressed RNA transcripts. These variations could provide important insights about several research applications such as cancer research, stem cell biology, immunology, developmental biology, and neurology. Single-cell analysis enables a closer view of the gene expression of individual cells to understand their functions in complex tissues.

Get The PDF Brochure of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2059

Kits and instruments based on technological platform such as Next Generation Sequencing (NGS), polymerase chain reaction (PCR), quantitative polymerase chain reaction (qPCR), and others provide high-throughput sequencing of individual cells. Single cell sequencing has significantly evolved with in-depth understanding of genomes and increasing genomic research to trace the root cause of many chronic diseases.

Single Cell Genome Sequencing Market Dynamics

Single cell genome sequencing is one of most focused area of research for finding cure for chronic disease such as cancer as it could help to observe tumor microenvironment. According to World Health Organization (WHO), cancer is one of leading non-communicable disease and second leading cause of death, worldwide. According to a report by International Age for Research on Cancer (IARC) in 2012, around 14.1 million new cases of cancer were registered with around 8.8 million death and around 32.6 million people are living with cancer in the year 2012.

Introduction of new therapies for the treatment of cancer such as personalized medicine (Immuno-oncology and others.) is expected to increase the adaption of single cell genomic sequencing for advancing research in order to observe cellular level changes in cancer cells.

Furthermore, application of single cell genomic sequencing in other diseases such as immune system disorder and infectious diseases (Tuberculosis, meningococcal disease, and others.) is a key factor contributing to the market growth. According to statistics given by Centers for Disease Control and Prevention 2017 Vital Signs, around 54.4 million U.S. adults suffer from arthritis – which is equivalent to 25% of the U.S. population. Rheumatoid arthritis which is leading autoimmune disorder holds significant share in the overall arthritis prevalence.

Single Cell Genome Sequencing Market - Competitive Landscape

Key players operating in the single cell genome sequencing market include, Illumina, Inc., Fludigim Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Inc., QIAGEN, Bio-Rad Laboratories, 10x Genomics, Novogene, BGI, Oxford Nanopore Technologies, and Pacific Biosciences

Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2059

Single Cell Genome Sequencing Market - Regional Insights

On the basis of Geography, single cell genome sequencing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be dominant in the market during forecast period. High prevalence of different types of cancer is witnessed in the U.S. According to a report by American cancer Society, 2018, cancer is the second leading cause of death after cardio vascular disease. The report further projected around 1.7 million new cases of cancer with around half million deaths, worldwide.

Single cell genome sequencing is utilized by several research institutes and commercial companies for revealing changes at gene level in single cell which could lead to potential therapies and access to develop new medicines.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Single Cell Genome Sequencing Market Clinical Review, Analysis And Synthesis 2018-2026 With Top Players Illumina, Fludigim Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche, QIAGEN here

News-ID: 1794160 • Views: 2126

More Releases from Coherent Market Insights - Biotechnology

Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy
Diabetes Vaccine Market Scrutinized in New Research 2018-2026
Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses. Diabetes vaccine is being developed to strengthen the body’s response against enterovirus

All 5 Releases


More Releases for Single

Single Cell Analysis Market
Single Cell Analysis Market Size Worth $ 4,752.19 Million By 2026 | CAGR: 18.4% The global Single Cell Analysis market size is expected to reach USD 4,752.19 million by 2026 according to a new study by WhipSmart MI Research. The report “Single Cell Analysis Market By Product (Consumables and Instruments), Cell Type (Human, Microbial and Animal), Technique (Flow Cytometers, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry and Other Techniques), Application
New Single Released to Radio
PRESS RELEASE FOR IMMEDIATE RELEASE Nov 2 | Posted by: Tribe Team New Single Released to Radio! Randy and his team have joined forces with Radio to release his New single "Saturday Backroad". He has been in Nashville working on the new project over a couple years since his 2011 KMA Records release. Now he's back ready to take the spot light and present all of his brand new music your sure to love. The
Single Cell Isolation Trends 2016
ReportsWorldwide has announced the addition of a new report Single Cell Isolation Trends 2016 to its growing collection of premium market research reports. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on single cell isolation carried out in December 2016. The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces. The objectives were to understand current interest, progress made in implementation and
Single Door Access Control Panel
COSEC ARC is an intelligent compact IP panel with PoE for a single door. ARC dramatically simplifies access deployment. COSEC ARC works in two modes – standalone with COSEC PANEL or in a centralized mode with COSEC CENTRA application server. The state-of-the-art COSEC ARC can control 2 readers on Wiegand or RS-485, door lock and other auxiliary devices making it an ideal solution for any access control installation. Key Features: • Compact,
NEW KINKOBRA SINGLE & VIDEO RELEASE
The Dutch rock band Kinkobra has released their new SINGLE & VIDEO "OK" worldwide over AWESOME KICKASS RECORDS on the 24th of august. After only three months, they convinced 3FM dj Annemieke Schollaardt to let them perform live in her show. Not much later, joining a Demo contest from Radio 538, this firmly established their potential. Next a live webcast for RedBull in cooperation with MTV
Hayden Padgett's Debut Single
Hayden Padgett, an up and coming artist based in the Bay Area, is releasing his latest single entitled "Poisoning Me." The song is a combination of Pop and R&B elements that highlights the piano skills of Hayden Padgett, as well as his vocal talent. The song is a strong first step in the musical career of a talented new artist. Hayden Padgett has been heavily involved in music for most of